Medications for Opioid Use Disorder- Addressing Opioid Use Disorder in General Medical Settings (2 credit hours)

Program Summary:  This course examines OUD in the general medical setting and offers guidance on screening, assessment, DSM-5 diagnosis, and treatment. Healthcare workers in general medical settings are seeing an increasing number of patients with OUD.  They are often a first contact for patients and the primary providers of ongoing clinical care. The course includes information on drug testing and shared decision-making between patients and providers.

“Effective integration of prevention, treatment, and recovery services across health care systems is key to addressing opioid misuse and its consequences and it represents the most promising way to improve access to and quality of treatment.”  –The Surgeon General’s Spotlight on Opioids

This course is recommended for social workers, counselors, and therapists and is appropriate for beginning and intermediate levels of practice.  

“Book  Open the Course Reading Here.

Course Reading:  Tip 63:  Medications for Opioid Use Disorder Parts 1 and 2

Publisher:  Substance Abuse and Mental Health Services Administration

Find the reading at:  

Course Objectives:  To enhance professional practice, values, skills, and knowledge by identifying key issues related to OUD medications and addressing opioid use disorder in general medical settings.

Learning Objectives:  Compare and contrast the three FDA-approved OUD medications.  Identify recommendations for screening in a general medical setting.  Identify key elements of a comprehensive assessment.  Describe the DSM-5 diagnostic criteria.  Compare OUD treatment settings.

Course Available Until: December 31, 2024.

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

1: For the following questions, please refer to Part 1 of the reading at https://www.freestatesocialwork.com/articles/tip63_fulldoc_052919_508.pdf.  Opioid addiction, which generally corresponds with moderate to severe forms of OUD, often requires ___________ for effective treatment.
 
 
2: Using Exhibit 1.1:   A process in which a person with OUD who has been in remission experiences a return of symptoms or loss of remission describes which of the following?
 
 
 
 
3: The TIP expert panel recommends that providers always use person-first language such as
 
 
 
 
4: Use Exhibit 1.2 for the following:  Which OUD medication is not a scheduled medication and not included in OTP regulations?
 
 
 
5: Which treatment has by far the largest, oldest evidence base of all treatment approaches to opioid addiction?
 
 
 
6: Which of the following has no regulations beyond those that apply to any prescription pharmaceutical?
 
 
 
7: The best results occur when a patient receives OUD medications
 
 
 
 
8: For the following questions, please refer to Part 2 of the reading at   https://www.freestatesocialwork.com/articles/tip63_fulldoc_052919_508.pdf.  The number of patients presenting with OUD in medical clinics, community health centers, and private practices is
 
 
9: Using Exhibit 2.1, Maintenance treatment is defined _________ a specific endpoint.
 
 
10: Using Exhibit 2.1, an opioid use disorder is applicable to a person who uses opioids and experiences at least ______________ of the 11 symptoms in a 12-month period.
 
 
 
 
11: Using Exhibit 2.3, what constitutes a positive screen for the NIAAA single-item question:  how many times in the past year have you had five or more drinks in a day (four drinks for women and adults older than 65)?
 
 
 
 
12: The TIP expert panel does not recommend
 
 
 
 
13: Assess patients for OUD if
 
 
 
 
14: Which question is more likely to encourage a patient to explore his/her own experiences?
 
 
15: Substance misuse substantially increases the risk of intimate partner violence.
 
 
16: The duration of opioid withdrawal depends on the specific opioid from which the patient is withdrawing and can last
 
 
 
 
17: Testing for a range of commonly used substances helps
 
 
 
 
18: Using Exhibit 2.12, which drug will or may screen negative on opiate screen?
 
 
 
 
19: A problematic pattern of opioid use leading to clinically significant impairment or distress, as manifested by at least two criteria, occurring within a 12-month period describes the DSM-5 criteria for
 
 
 
20: Ensuring that patients understand the risks and benefits of all options for treatment allows for
 
 
 
 
21: Using Exhibit 2.14, which OUD medication has no withdrawal symptoms on discontinuation?
 
 
 
22: Which patients may be appropriate candidates for residential treatment?
 
 
 
 
23: Confidentiality regulations prohibit specialty SUD treatment programs from sharing information with healthcare professionals about patient's SUD treatment without specific consent from patients
 
 
24: When referrals are indicated, it is better to
 
 

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

 

Free State Social Work, LLC, provider #1235, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 9/6/2021 - 9/6/2024. Social workers completing this course receive 2 clinical continuing education credits.

Free State Social Work has been approved by NBCC as an Approved Continuing Education Provider, ACEP NO. 6605. Programs that do not qualify for NBCC credit are clearly identified. Free State Social Work is solely responsible for all aspects of the programs.

G.M. Rydberg-Cox, MSW, LSCSW is the Continuing Education Director at Free State Social Work and responsible for the development of this course.  She received her Masters of Social Work in 1996 from the Jane Addams School of Social Work at the University of Illinois-Chicago and she has over 20 years of experience.  She has lived and worked as a social worker in Chicago, Boston, and Kansas City. She has practiced for many years in the area of hospital/medical social work.  The reading materials for this course were developed by another organization.

Course Available Until: December 31, 2024.
Filed under: Addiction, Clinical, Healthcare, Opioids